Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases
Dietger Niederwieser(Leipzig University of Applied Sciences), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David G. Maloney(Fred Hutch Cancer Center), Wolfram Pönisch(United States Department of Veterans Affairs), Thomas R. Chauncey(City Of Hope National Medical Center), Ann E. Woolfrey(University of Washington), Thoralf Lange, Effie W. Petersdorf(University of Washington), Claudio Anasetti(Moffitt Cancer Center), Barry E. Storer(City Of Hope National Medical Center), Ute Hegenbart(Heidelberg University), Brenda M. Sandmaier(University of Washington), Peter A. McSweeney(Mesoblast (United States)), Marie-Térèse Little(United States Department of Veterans Affairs), Karl G. Blume(City Of Hope National Medical Center), Michael W. Deininger(Versiti Blood Center of Wisconsin), Michael B. Maris(Colorado Blood Cancer Institute), Judith A. Shizuru(Stanford University)
Cited by 457
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k